These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23966785)

  • 1. A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophrenia.
    Caccia S; Invernizzi RW; Nobili A; Pasina L
    Ther Clin Risk Manag; 2013; 9():319-28. PubMed ID: 23966785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cariprazine for the Treatment of Schizophrenia: A Review of this Dopamine D3-Preferring D3/D2 Receptor Partial Agonist.
    Citrome L
    Clin Schizophr Relat Psychoses; 2016; 10(2):109-19. PubMed ID: 27440212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy.
    Citrome L
    Neuropsychiatr Dis Treat; 2018; 14():2563-2577. PubMed ID: 30323605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cariprazine for bipolar depression: What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2019 Oct; 73(10):e13397. PubMed ID: 31355510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical potential of cariprazine in the treatment of acute mania.
    Altınbaş K; Guloksuz S; Oral ET
    Psychiatr Danub; 2013 Sep; 25(3):207-13. PubMed ID: 24048386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cariprazine to Treat Schizophrenia and Bipolar Disorder in Adults.
    Edinoff A; Ruoff MT; Ghaffar YT; Rezayev A; Jani D; Kaye AM; Cornett EM; Kaye AD; Viswanath O; Urits I
    Psychopharmacol Bull; 2020 Sep; 50(4):83-117. PubMed ID: 33012874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability.
    Citrome L
    Expert Opin Drug Metab Toxicol; 2013 Feb; 9(2):193-206. PubMed ID: 23320989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cariprazine in schizophrenia: clinical efficacy, tolerability, and place in therapy.
    Citrome L
    Adv Ther; 2013 Feb; 30(2):114-26. PubMed ID: 23361833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in the management of schizophrenia and bipolar disorder: potential use of cariprazine.
    Werner FM; Coveñas R
    Ther Clin Risk Manag; 2015; 11():1657-61. PubMed ID: 26586950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cariprazine in bipolar disorder: clinical efficacy, tolerability, and place in therapy.
    Citrome L
    Adv Ther; 2013 Feb; 30(2):102-13. PubMed ID: 23361832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment).
    Nakamura T; Kubota T; Iwakaji A; Imada M; Kapás M; Morio Y
    Drug Des Devel Ther; 2016; 10():327-38. PubMed ID: 26834462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial.
    Durgam S; Starace A; Li D; Migliore R; Ruth A; Németh G; Laszlovszky I
    Bipolar Disord; 2015 Feb; 17(1):63-75. PubMed ID: 25056368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cariprazine: A new partial dopamine agonist with a familiar profile.
    Hope J; Keks NA
    Australas Psychiatry; 2022 Jun; 30(3):382-385. PubMed ID: 35156402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies.
    Barabássy Á; Sebe B; Acsai K; Laszlovszky I; Szatmári B; Earley WR; Németh G
    Neuropsychiatr Dis Treat; 2021; 17():957-970. PubMed ID: 33854317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine : A Review of its Use in Schizophrenia.
    Gunasekara NS; Spencer CM
    CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cariprazine in Three Special Different Areas: A Real-World Experience.
    Gesi C; Paletta S; Palazzo MC; Dell'Osso B; Mencacci C; Cerveri G
    Neuropsychiatr Dis Treat; 2021; 17():3581-3588. PubMed ID: 34908838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cariprazine, a new, orally active dopamine D2/3 receptor partial agonist for the treatment of schizophrenia, bipolar mania and depression.
    Veselinović T; Paulzen M; Gründer G
    Expert Rev Neurother; 2013 Nov; 13(11):1141-59. PubMed ID: 24175719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, Safety, and Tolerability of Cariprazine in Pediatric Patients with Bipolar I Disorder or Schizophrenia.
    Riccobene T; Riesenberg R; Yeung PP; Earley WR; Hankinson AL
    J Child Adolesc Psychopharmacol; 2022 Oct; 32(8):434-443. PubMed ID: 36282772
    [No Abstract]   [Full Text] [Related]  

  • 20. Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety.
    Laszlovszky I; Barabássy Á; Németh G
    Adv Ther; 2021 Jul; 38(7):3652-3673. PubMed ID: 34091867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.